RxDoctor Payments Data

Sarah Studyvin, DO

Pediatric Cardiology · Indianapolis, INNPI 1568880227

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 14.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,574 and has fallen 89.5% since, to $165 in 2025.

$2,903in general payments, 2019–2025

Across 86 payments — averaging $33.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$414
  • Inari Medical, Inc.$273
  • Johnson & Johnson$245
  • Pfizer$235
  • E.r. Squibb & Sons, L.L.C.$232
  • AstraZeneca$228
  • plus $1K from 11 others

What the payments were for

  • Food & beverage$2,903100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,903 in reported general payments places this provider in the 80th percentile of 34 pediatric cardiology providers in Indiana.

See all pediatric cardiology providers in Indiana

Medicare billing

Part B allowed, 2024
$5,819
Medicare patients
25
Services billed
72

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Spironolactone15$54
Furosemide18$37

Paid to pharmacies, not to this prescriber.

Other pediatric cardiology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →